Home / Artifacts / JAK Inhibitors in Parkinson's Disease

📖

JAK Inhibitors in Parkinson's Disease

active

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-companies-jak-inhibitors-parkinsons

Related Entities

companies-jak-inhibitors-parkinsons

Metadata

slug	companies-jak-inhibitors-parkinsons
kg_node_id	None
entity_type	company

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

Outgoing

0 supporting 0 contradicting 0 neutral

View full evidence profile →

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

This artifact has no version history yet.

Linked Artifacts (184)

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%

see_also📖NME1 - NME Nucleoside Diphosphate Kinase 160%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%

see_also📖MAPK10 Gene60%

see_also📖JAK3 Gene60%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%

related🧫Macroautophagy Dysfunction in PD - Experiment Design60%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%

see_also📖LEPR — Leptin Receptor60%

see_also📖STAT2 Gene - Signal Transducer and Activator of Transcriptio60%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%

see_also📖steap360%

see_also📖KMT2D — Lysine Methyltransferase 2D60%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%

see_also📖chromatin-remodeling-neurodegeneration60%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%

see_also📖STAT5A Gene60%

see_also📖NPTXR — Neuronal Pentraxin Receptor60%

see_also📖ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 260%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%

related🧫Validation: Membrane-Nucleation in iPSC Neurons60%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

related🧫MLCS Quantification in Parkinson's Disease60%

related🧫CRISPR Gene Correction Approaches for CBS/PSP60%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%

see_also📖NPY1R Gene60%

related🧫Experiment: Multi-Ethnic PD GWAS60%

see_also📖Chromatin Remodeling and Epigenetic Therapy Synthesis for Ne60%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%

see_also📖IL11 Gene60%

related🧫Cytochrome Therapeutics60%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%

see_also📖JARID260%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%

see_also📖Packard Center for ALS Research60%

see_also📖AKT1 Gene60%

see_also📖Chromatin Remodeling in Neurodegeneration60%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%

see_also📖prkaca Gene60%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%

see_also📖SIGLEC1 Gene60%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%

related🧫Ferroptosis Validation in Parkinson's Disease60%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%

related🧫Antiviral Therapy Trial for Parkinson's Disease60%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%

related🧫AAV-LRRK2 IND-Enabling Study Design60%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%

related🧫Prodromal Parkinson's Disease Biomarker Development — E60%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%

see_also📖IFNAR2 — Interferon Alpha Receptor 260%

see_also📖STAT4 Gene60%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

see_also📖socs160%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%

related🧫Combination Therapy Sequencing in Parkinson's Disease60%

related🧫Parkinson's Disease Subtype Classification — Precision 60%

related🧫Alpha-Synuclein Seed Amplification Assay Validation60%

related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%

related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%

related🧫Parkinson's Disease Subtype Classification — Precision 54%

related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%

related🧫Ferroptosis Validation in Parkinson's Disease54%

related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%

related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%

related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%

related🧫Macroautophagy Dysfunction in PD - Experiment Design54%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%

related🧫Experiment: Multi-Ethnic PD GWAS54%

related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%

related🧫MLCS Quantification in Parkinson's Disease54%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%

related🧫Antiviral Therapy Trial for Parkinson's Disease54%

related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%

related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%

related🧫Validation: Membrane-Nucleation in iPSC Neurons54%

related🧫AAV-LRRK2 IND-Enabling Study Design54%

related🧫Cytochrome Therapeutics54%

related🧫Combination Therapy Sequencing in Parkinson's Disease54%

related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%

related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%

related🧫CRISPR Gene Correction Approaches for CBS/PSP54%

related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%

related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%

related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%

related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%

related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%

related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%

related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%

related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%

related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%

related🧫Prodromal Parkinson's Disease Biomarker Development — E54%

related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%

related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%

related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%

related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%

related🧫Alpha-Synuclein Seed Amplification Assay Validation54%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%

related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%

related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

related🔬The disease-associated microglia (DAM) phenotype involves TR50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪HSP90-Tau Disaggregation Complex Enhancement50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What are the mechanisms underlying what are the mechanisms b50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪VCP-Mediated Autophagy Enhancement50%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

mentions🔬What are the mechanisms underlying what are the mechanisms b40%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%

mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%

💬 Discussion

Loading comments...